PL381603A1 - Preparat zawierający maślan sodu i zastosowanie preparatu zawierającego maślan sodu - Google Patents
Preparat zawierający maślan sodu i zastosowanie preparatu zawierającego maślan soduInfo
- Publication number
- PL381603A1 PL381603A1 PL381603A PL38160307A PL381603A1 PL 381603 A1 PL381603 A1 PL 381603A1 PL 381603 A PL381603 A PL 381603A PL 38160307 A PL38160307 A PL 38160307A PL 381603 A1 PL381603 A1 PL 381603A1
- Authority
- PL
- Poland
- Prior art keywords
- preparation containing
- containing sodium
- sodium butyrate
- application
- butyrate
- Prior art date
Links
- MFBOGIVSZKQAPD-UHFFFAOYSA-M sodium butyrate Chemical compound [Na+].CCCC([O-])=O MFBOGIVSZKQAPD-UHFFFAOYSA-M 0.000 title 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL381603A PL216229B1 (pl) | 2007-01-25 | 2007-01-25 | Preparat zawierający maślan sodu i zastosowanie preparatu zawierającego maślan sodu |
| EP08705167.8A EP2114391B1 (en) | 2007-01-25 | 2008-01-22 | A preparation containing sodium butyrate and the application of a preparation containing sodium butyrate |
| PCT/PL2008/000008 WO2008091170A1 (en) | 2007-01-25 | 2008-01-22 | A preparation containing sodium butyrate and the application of a preparation containing sodium butyrate |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL381603A PL216229B1 (pl) | 2007-01-25 | 2007-01-25 | Preparat zawierający maślan sodu i zastosowanie preparatu zawierającego maślan sodu |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL381603A1 true PL381603A1 (pl) | 2008-08-04 |
| PL216229B1 PL216229B1 (pl) | 2014-03-31 |
Family
ID=39269830
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL381603A PL216229B1 (pl) | 2007-01-25 | 2007-01-25 | Preparat zawierający maślan sodu i zastosowanie preparatu zawierającego maślan sodu |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP2114391B1 (pl) |
| PL (1) | PL216229B1 (pl) |
| WO (1) | WO2008091170A1 (pl) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL382831A1 (pl) * | 2007-07-03 | 2009-01-05 | Paweł Michałowski | Preparat stanowiący dodatek paszowy zawierający mieszaninę maślanu sodu i kwasów organicznych oraz wyciągu z Yucca Schidigeri i zastosowanie preparatu do wytwarzania środka leczniczego do leczenia wspomagającego układ pokarmowy |
| GB2466041A (en) * | 2008-12-09 | 2010-06-16 | Sanluc Internat Nv | Coated granules comprising butyrate salt |
| GB0903016D0 (en) * | 2009-02-23 | 2009-04-08 | Univ Gent | Method for alleviating intestinal problems and novel bacterial strains therefor |
| HRP20150100T1 (hr) * | 2010-04-26 | 2015-05-08 | Angel Manuel Gago De Santos | Pripravci za simptomatsko olakšavanje boli u želucu ili gastroezofagealnog refluksa |
| PL395945A1 (pl) * | 2011-08-12 | 2013-02-18 | Tomasz Banasiewicz | Zapobieganie oraz ograniczanie wystepowania biegunek, w szczególnosci u podróznych udajacych sie do krajów podwyzszonego ryzyka, i sposób produkcji preparatów stosowanych w tym celu |
| NL2009744C2 (en) | 2012-11-02 | 2014-05-06 | Palital Gmbh & Co Kg | New method to compose and process an animal feed additive with butyrate. |
| US20180353447A1 (en) * | 2015-11-27 | 2018-12-13 | Birrbeheer B.V. | Butyrate salts for use in inflammatory diseases |
| WO2017172894A2 (en) * | 2016-03-30 | 2017-10-05 | The Trustees Of Columbia University In The City Of New York | Methods of preventing, treating and detecting colorectal cancer using butyrate producing bacteria |
| AU2018255269B2 (en) | 2017-04-17 | 2023-03-09 | The University Of Chicago | Polymer materials for delivery of short-chain fatty acids to the intestine for applications in human health and treatment of disease |
| PL236296B1 (pl) * | 2017-08-25 | 2020-12-28 | Przed Produkcji Farmaceutycznej Hasco Lek Spolka Akcyjna | Tabletka zawierająca maślan sodu i sposób jej wytwarzania |
| PL237391B1 (pl) * | 2018-09-18 | 2021-04-06 | Axxis Pharma Spolka Z Ograniczona Odpowiedzialnoscia | Preparat doustny zawierający maślan sodu |
| GB202004690D0 (en) * | 2020-03-31 | 2020-05-13 | Edinburgh Napier Univ | Composition for enhancing immune response of cells |
| FR3120288A1 (fr) * | 2021-03-05 | 2022-09-09 | Idcaps | Granules contenant une substance active, leur procédé de préparation et leur utilisation en alimentation humaine ou animale. |
| IT202200003929A1 (it) * | 2022-03-02 | 2023-09-02 | Difass Int S P A | Composizioni per il trattamento di patologie e sindromi legate a disfunzioni della barriera intestinale e alla disbiosi |
| PL247439B1 (pl) * | 2022-10-07 | 2025-06-30 | Probiome Spolka Z Ograniczona Odpowiedzialnoscia | Czopki doodbytnicze oraz ich zastosowanie |
| PL445850A1 (pl) * | 2023-08-18 | 2025-02-24 | Nerr Pharma Spółka Z Ograniczoną Odpowiedzialnością | Preparat doustny zawierający sole kwasu masłowego oraz jego zastosowanie |
| PL446457A1 (pl) * | 2023-10-22 | 2025-04-28 | Probiome Spółka Z Ograniczoną Odpowiedzialnością | Granulat zawierający związek maślanu, jednostkowa postać dawkowania go zawierająca oraz jego nowe zastosowanie |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995013801A1 (en) * | 1993-11-17 | 1995-05-26 | Commonwealth Scientific And Industrial Research Organisation | Fatty acid delivery system |
| ITMI20021427A1 (it) * | 2002-06-28 | 2003-12-29 | Vetagro S R L | Composizioni per uso nell'alimentazione animale comprendente una matrice a rilascio controllato procedimento di preparazione e relativo impi |
| PL382831A1 (pl) * | 2007-07-03 | 2009-01-05 | Paweł Michałowski | Preparat stanowiący dodatek paszowy zawierający mieszaninę maślanu sodu i kwasów organicznych oraz wyciągu z Yucca Schidigeri i zastosowanie preparatu do wytwarzania środka leczniczego do leczenia wspomagającego układ pokarmowy |
-
2007
- 2007-01-25 PL PL381603A patent/PL216229B1/pl unknown
-
2008
- 2008-01-22 WO PCT/PL2008/000008 patent/WO2008091170A1/en not_active Ceased
- 2008-01-22 EP EP08705167.8A patent/EP2114391B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| PL216229B1 (pl) | 2014-03-31 |
| EP2114391B1 (en) | 2020-09-16 |
| WO2008091170A1 (en) | 2008-07-31 |
| EP2114391A1 (en) | 2009-11-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL381603A1 (pl) | Preparat zawierający maślan sodu i zastosowanie preparatu zawierającego maślan sodu | |
| ZA201203938B (en) | Portion capsule and use of a portion capsule | |
| PL1982964T3 (pl) | Mieszanina zawierająca związek krzemoorganiczny i jej zastosowanie | |
| ZA201001051B (en) | Benzylbenzene derivatives and methods of use | |
| IL213817A0 (en) | Orosoluble and/or effervescent compositions containing at least a salt of s-adenosyl methionine (same) | |
| EP2097513A4 (en) | MANUFACTURE AND USE OF CELLS SYNTHETIZED FIBS | |
| GB2458228B (en) | External preparation for skin | |
| PL2097457T3 (pl) | Pochodne kwasowych polisacharydów | |
| EP2094665A4 (en) | PREPARATION OF MONTELUKAST AND ITS SALTS | |
| EP1994042A4 (en) | PREPARATION OF GEMCITABINE | |
| GB201103179D0 (en) | Combining interfaces of shell applications and sub-applications | |
| ZA201103752B (en) | Cycloundecadepsipeptide compounds and use of said compounds as a medicament | |
| IL196594A0 (en) | Derivatives of 4-trimethylammonium-3-aminobutyrate and 4-trimethylphosphonium-3-aminobutyrate as cpt-inhibitors | |
| ZA201005442B (en) | Pharmaceutical compositions of amlodipine and valsartan | |
| IL196606A0 (en) | Use of escin | |
| PT2137212E (pt) | Preparação de soluções de manoproteína | |
| PL2010732T3 (pl) | Podłużny element zakończeniowy z gipsu | |
| IL200087A0 (en) | Novel crystal of piperacillin sodium | |
| IL182984A (en) | Preparation of borohydride salts | |
| IL196320A0 (en) | Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones | |
| GB0701755D0 (en) | Debugging of master documents | |
| SI2079472T1 (sl) | Priprava velikih količin stansoporfina z visoko čistoto | |
| IL192552A0 (en) | Dnt-succinate and methods of preparation thereof | |
| PL385130A1 (pl) | Sposób zabezpieczenia oryginalności chleba | |
| IL191918A0 (en) | Fluvastatin sodium novel forms and preparation thereof |